Veterinary Medicine Information website

NAFPENZAL DC (300+100+100)MG/3G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium monohydrate
  • Benzylpenicillin procaine
Download as PDF

Product identification

Medicine name:
NAFPENZAL DC (300+100+100)MG/3G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium monohydrate
  • Benzylpenicillin procaine
Target species:
  • Goat
  • Cattle
  • Sheep
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Nafcillin sodium monohydrate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benzylpenicillin procaine
    300.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Goat
      • Meat and offal
        35
        day
      • Milk
        9
        day
    • Cattle
      • Meat and offal
        16
        day
      • Milk
        48
        hour
    • Sheep
      • Meat and offal
        35
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51GA90
  • QJ51RC
  • QJ51RC22
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 18132/09-03-2009/K-0112802
Date of authorisation status change: